… NSCLC, but its role in patients harboring EGFR mutations … of uncommon mutations to
currently available EGFR TKIs is … patients harboring uncommon EGFR mutations with currently …

… In conclusion, uncommon EGFR mutations may be associated with a poor outcome and the
… in cases of double uncommon mutations and such patients should be treated accordingly. …

… Our findings suggested that only patients with rare EGFR mutations could receive platinum-…
and short PFS in response to EGFR-TKIs. Consequently, EGFR-TKIs could be reserved as a …

… against major uncommon EGFR mutations including compound mutations, but … uncommon
EGFR mutations. Moving forward, it will be important to include uncommon EGFR mutations …

… uncommon EGFR mutations and their sensitivity to EGFR … patients harboring uncommon
EGFR mutations with treatment … 95 Patients who received therapy that consisted of EGFR TKIs …

… Here, we describe a case of a patient with advanced NSCLC with an uncommon EGFR
mutation who was treated with pulse dose weekly afatinib with durable and tolerable disease …

… receptor (EGFR) tyrosine kinase inhibitors (… mutations in the EGFR. However, limited data
are available regarding the activity of available EGFR TKIs against uncommon EGFR mutations…

… clinical reference of the sensitivity of uncommon EGFR mutations to EGFR-TKIs, we have …
deal with uncommon mutations. In this review, we systematically categorized these mutations, …

… uncommon EGFR mutations, treated in our Institution with first or second generation TKIs. …
only), this review underlines that uncommon EGFR mutations are an heterogeneous group of …

… uncommon EGFR mutations, such as their association with the effectiveness of EGFR tyrosine
kinase inhibitors (… of these uncommon EGFR mutations of unknown clinical significance. …